Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID‐19 vaccinations, Western Australia, 22 February to 30 June 2021

Within the first 4 months of the Western Australian COVID‐19 immunisation programme, 49 suspected anaphylaxis cases were reported to the vaccine safety surveillance system. Twelve reports met Brighton Collaboration case definition, corresponding to rates of 15.9 and 17.7 per million doses of Vaxzevr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal medicine journal 2023-02, Vol.53 (2), p.275-279
Hauptverfasser:	Shivarev, Alexander, Phillips, Anastasia, Brophy‐Williams, Sam, Ford, Tim, Richmond, Peter, Effler, Paul, McLean‐Tooke, Andrew
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse Drug Reaction Reporting Systems AEFI Anaphylaxis Anaphylaxis - etiology Australia - epidemiology BNT162 Vaccine ChAdOx1 nCoV-19 Comirnaty COVID-19 COVID-19 - etiology COVID-19 Vaccines - adverse effects COVID‐19 vaccines Humans Immunization Vaccination - adverse effects Vaxzevria Western Australia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Within the first 4 months of the Western Australian COVID‐19 immunisation programme, 49 suspected anaphylaxis cases were reported to the vaccine safety surveillance system. Twelve reports met Brighton Collaboration case definition, corresponding to rates of 15.9 and 17.7 per million doses of Vaxzevria and Comirnaty administered respectively.
ISSN:	1444-0903 1445-5994
DOI:	10.1111/imj.16001